Abstract Purpose: Adenocarcinoma arises in Barrett's esophagus by progression from metaplasia to cancer through grades of dysplasia. Our aim in this exploratory study was to characterize the broad changes in gene expression that underlie this histologic progression to cancer and assess the potential for using these gene expression changes as a marker predictive of malignant progression in Barrett's epithelium. Experimental Design: Microarray analysis was used to obtain individual gene expression profiles from endoscopic biopsies of nine esophageal adenocarcinomas and the Barrett's epithelia from which three of the cancers had arisen. Pooled samples from the Barrett's epithelia of six patients without cancer or dysplasia served as a reference.
Barrett's esophagus is a premalignant condition predisposing to development of adenocarcinoma (1, 2) . In Barrett's esophagus, normal squamous epithelium is replaced by a columnar metaplastic epithelium in response to mucosal injury from chronic gastroesophageal reflux. Adenocarcinoma arises in a Barrett's esophagus by sequential progression from metaplasia to cancer through grades of dysplasia (1, 3) . To explain this sequence of neoplastic progression, it has been proposed that environmental factors trigger increased cell proliferation, which predisposes cells to genetic mutation (4) . Cell proliferation is further deregulated by genetic mutation, with accumulation of additional genetic abnormalities. This interaction of genomic instability and abnormal cell proliferation eventually may lead to accumulation of critical genetic errors in clones of cells, making them capable of malignant invasion.
Sequential progression from Barrett's epithelial metaplasia to cancer occurs over years, affording clinicians the opportunity to detect high-grade dysplasia or curable early-stage adenocarcinoma by endoscopic surveillance. However, use of dysplasia as a marker of malignant potential in Barrett's esophagus has shortcomings, including disagreement in histologic interpretation among pathologists and sampling error in biopsies (5, 6) . For this reason, investigators have studied a large number of biological markers in search of an alternative to dysplasia as a marker of malignant potential (4, 7) . Abnormalities in oncogenes, growth regulatory factors, and tumor suppressor genes have been described at different stages in the neoplastic progression of Barrett's esophagus (8) . The complexity of genetic abnormalities may explain why no single genetic marker has been found to replace dysplasia as a marker of malignant potential.
The aim of this exploratory study was to use genome-wide expression profiling to characterize the broad changes in gene expression that underlie progression to esophageal adenocarcinoma from a Barrett's epithelium and assess the potential for using these gene expression changes as a marker predictive of malignant progression in Barrett's epithelium. We used microarray-based expression profiling to determine the changes in gene expression that occurred in esophageal adenocarcinoma and the Barrett's epithelium from which it arises. Genome-wide expression profiling is well suited for exploring the complexity of genetic abnormalities associated with the neoplastic progression of Barrett's metaplasia to cancer because of its ability to evaluate thousands of genes from multiple tissues simultaneously.
Materials and Methods
Ten endoscopic biopsy specimens were taken from the tumor in each of nine patients with adenocarcinoma of the esophagus using a standard 2.2 mm forceps. Six of these patients had adenocarcinoma without Barrett's epithelium evident at endoscopy, whereas in the other three patients the cancer had arisen from an adjacent Barrett's epithelium. Ten biopsy specimens were taken from each of the three Barrett's epithelia from which cancer had arisen. A further 10 biopsies were taken from the Barrett's epithelium in each of six additional patients with Barrett's esophagus who had neither cancer nor dysplasia. Biopsy specimens were placed in cryogenic vials and immediately dipped in liquid nitrogen to freeze the tissue and thus preserve the RNA. This study protocol was approved by the University of South Florida Institutional Review Board.
Biopsy specimens were examined by frozen section technique and microdissected to eliminate areas containing normal adjacent tissue, intervening stroma, and necrotic debris. Microdissection was done with a scalpel tip by a single pathologist (D.C.). Although it was not possible to eliminate all stroma and debris, microdissection of tumors by this method has been judged to yield tissue containing >90% tumor cells (9) . For specimens from each patient, total RNA was prepared by Trizol (Invitrogen, Carlsbad, CA) extraction and the yield was measured. Integrity of extracted RNA was verified by both gel electrophoresis and the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). We found that 10 endoscopic biopsy specimens obtained from an esophageal adenocarcinoma and processed in this way typically would yield 50 to 100 Ag total RNA, a quantity that far exceeded the minimum 5 Ag needed for the subsequent microarray analysis. Samples were either pooled in equimolar amounts or used independently for GeneChip (Affymetrix, Santa Clara, CA) hybridization.
All experiments used the Human Hu U133A GeneChip, which contains 22,214 probe sets that survey expression level of >15,000 named genes based on the National Center for Biotechnology Information UniGene Build 133 (Affymetrix). Each chip was hybridized using targets synthesized from 5 Ag of starting material (total RNA). Pooled samples were made by combining equal amounts of total RNA from each component tissue to obtain 5 Ag total RNA for study (9) . Target synthesis, hybridization, and posthybridization staining were done using standard Affymetrix protocols (10) . Stained chips were scanned on an Affymetrix GeneArray Scanner. Scanned output files were visually inspected for hybridization artifacts and then analyzed by using Affymetrix Microarray suite software version 5.0. This software uses a statistical algorithm to assess increases or decreases in mRNA abundance in a direct comparison between two samples (11) .
Results
To identify gene expression changes in cancers and the Barrett's epithelia from which cancer had arisen, we used Barrett's epithelia from six patients who had neither cancer nor dysplasia as the reference tissue for comparison. RNA from the six patients' samples was pooled and then hybridized to a single U133A chip to obtain the reference gene expression profile. Pooled samples have been shown to accurately reflect gene expression in individual samples and yield reproducible data (9) . RNA samples from the nine cancers and the Barrett's epithelia from which three of these cancers had arisen were each hybridized to individual U133A chips. Pairwise comparisons to the reference Barrett's epithelia then were done to determine changes in gene expression for each cancer and Barrett's epithelium from which cancer had arisen.
Of >15,000 genes surveyed by microarray analysis, 1,097 different genes exhibited expression changes in cancers and the Barrett's epithelia from which cancer had arisen. To make this list, a gene expression change was required to have been found in each of the three Barrett's epithelia from which cancer had arisen, each of the three cancers arising from the Barrett's epithelia, or at least five of the six cancers without identifiable adjacent Barrett's epithelium. In nearly all cases, a gene expression change found in the Barrett's epithelia was also found in the cancers that had arisen from them. A complete list of differentially expressed genes may be obtained online (http://mriweb.moffitt.usf.edu/mpv/) or from the authors on request. In general, oncogenes, such as the cyclins A, D 1 , D 2 , D 3 , and E, were not overexpressed in cancer and the Barrett's epithelia from which cancer had arisen, and tumor suppressor genes, such as p53, and the cyclin-dependent kinase inhibitors p16, p21, and p27, were not underexpressed. The great majority of differentially expressed genes identified in this analysis do not exhibit functions that are usually considered to play a role in tumorigenesis.
We found few changes in expression of genes involved in regulation of the cell cycle whether in cancers or in the Barrett's epithelia from which cancer had arisen. Specifically, expression was not substantially or consistently different for genes governing cyclins and cyclin-dependent kinases, their inhibitors, or important substrates experimentally shown to have a major impact on control of cell growth. In the few instances in which a change was observed, the change was in a direction opposite to that expected. For example, expression of the gene cyclin D2, which promotes cell cycle progression, was observed to decrease an average of 1.8-fold in seven of nine cancers, whereas expression of genes governing the possible tumor suppressors ras-induced senescence 1 (RIS1) and hypermethylated in cancer 2 (HIC2) was increased f4-fold. The one example of differential gene expression for a cell cycle regulator that might promote unregulated cell growth is CDC25B, which is a dual specificity phosphatase that activates the mitosis-promoting kinase CDC2 by dephosphorylation (12) . Gene expression for CDC25B was increased in eight of nine cancers by f2-fold. Yet, this change may have been counterbalanced by an equal 2-fold increase in WEE1, which catalyzes the inhibitory phosphorylation of CDC2.
Other genes that might contribute to tumorigenesis exhibited similarly low-level changes in expression. Programmed cell death 4 and 10 (PDCD4 and PDCD10), genes induced during apoptosis, were down-regulated in all cancers, as were transcripts of caspase-6 and caspase-7, whereas baculoviral inhibitors of apoptosis repeat-containing 5 (BIRC5), also known as survivin, and SERPINB9, which can inhibit caspases, were increased. Changes in expression of genes involved in repair of DNA damage were found in cancers and the Barrett's epithelium from which cancer had arisen, but only XRCC4 was down-regulated. Loss of this protein, which is necessary for nonhomologous end joining and repair of double-strand breaks in DNA, can lead to genetic instability and further genetic changes (13) . Expression of several other DNA repair genes was increased in cancers.
Although >1,000 genes were differentially expressed in cancers or the Barrett's epithelia from which cancer had arisen, the increase or decrease in any single transcript was usually relatively small, with the average change being <4-fold for most genes. The low magnitude of these changes led us to use hierarchical clustering analysis to look for patterns in the gene expression profiles that could be used to classify specimens into four groups: cancer without identifiable Barrett's epithelium, cancer arising from a Barrett's epithelium, Barrett's epithelium from which cancer had arisen, and the reference Barrett's epithelia without cancer or dysplasia. Clustering analysis using data from all probe sets on each microarray failed to clearly delineate these groups. Restriction of the analysis to only the 1,097 genes that displayed differential expression was more successful but still did not classify specimens into entirely distinct groups (Fig. 1) . Cancers arising from a Barrett's epithelium tended to cluster together with the Barrett's epithelia from which they had arisen, whereas cancers without identifiable Barrett's epithelium tended to cluster away.
We individually compared gene expression changes in the three Barrett's epithelia from which cancer had arisen to the corresponding histology of each specimen. The microdissected specimen of Barrett's epithelium from one patient consisted entirely of high-grade dysplasia, whereas specimens from the other two patients were entirely metaplasia without dysplasia. The two entirely metaplastic epithelia exhibited changes in gene expression, suggesting that gene expression changes precede the development of dysplasia (Table 1 ). In the specimen with highgrade dysplasia, the number of gene expression changes (both underexpression and overexpression) exceeded that in the two specimens with only metaplasia and more closely resembled that observed in cancers, which contained the greatest number of gene expression changes.
Gene expression in Barrett's epithelium predicting progression to cancer. We compared gene expression in the individual Barrett's epithelia from which three cancers had arisen to the pooled reference Barrett's epithelia to determine the potential for finding gene expression changes that might predict progression to adenocarcinoma. Gene underexpression was the dominant change in each of the Barrett's epithelia from which cancer had arisen, suggesting possible loss of function as being of importance early on in the progression to cancer (Table 1) . Underexpressed genes included those governing differentiation-specific functions, protection against oxidative damage, and detoxification of xenobiotics, whereas overexpressed genes included those associated with immune function and inflammation ( Table 2) .
The predominant change in gene expression in both cancers and the Barrett's epithelia from which cancer had arisen was the down-regulation of differentiation-specific genes governing gastrointestinal mucosal functions, such as transport, mucous secretion, and metabolism of steroids and lipoproteins. We specifically considered markers indicative of enterocytic differentiation, such as sucrase-isomaltase (SI), cytokeratin 20 (KRT20), and various mucins. In general, genes for these markers were well expressed in reference Barrett's epithelia but substantially down-regulated in cancer and Barrett's epithelia from which cancer had arisen. For example, gene expression for sucrase-isomaltase was, on average, 50-fold less in cancers. Yet, there also was considerable variation among individuals. One adenocarcinoma produced transcript at a level nearly identical to the reference Barrett's epithelia, whereas a single individual Barrett's epithelium from the reference group exhibited little sucrase-isomaltase gene expression.
Transcripts for several proteins with a putative role in cellular defense against oxidative damage were reduced in Barrett's epithelia from which cancer had arisen. These genes included glutathione peroxidase (GPX2), selenoprotein P (SEPP1), and paraoxonase 2 and 3 (PON2 and PON3). Reduced expression of peroxiredoxin 2 (PRDX2) and thioredoxin (TXN) in some cancers could further impair cellular resistance to oxidative damage. Yet, some cancers also showed increased expression of superoxide dismutase 2 (SOD2), which could be protective.
Expression of genes involved in detoxification of xenobiotics was decreased in Barrett's epithelia from which cancer had arisen. Transcripts for several cytochrome P 450s and glycosyltransferases were down-regulated. Expression of flavin-containing mono-oxygenase 5 (FMO5), arylacetamide deacetylase (AADAC), some ATP-binding cassette transporters associated with the export of xenobiotics, and several members of the aldo-keto reductase family was reduced as well. Decrease in these normal epithelial protective functions could increase cancer risk.
We unexpectedly found changes in expression of several autosomal genes ordinarily considered male specific. Several genes located on the Y chromosome were greatly decreased in both cancers and the Barrett's epithelia from which cancer had arisen: deleted in azoospermia 2, 3, and 4 (DAZ2, DAZ3, and DAZ4) and testes-specific protein, Y-linked (TSPY). Only four such genes were slightly up-regulated in the cancers: SOX9 (involved in early development of males), guanine nucleotide binding protein h5 (GNB5), sperm-associated antigen 9 (SPAG9), and sperm adhesion molecule 1 (SPAM1).
We developed a list of candidate gene predictors of progression to cancer (Table 3) . These genes were chosen from those that exhibited a change in expression in all three Barrett's epithelia from which cancer had arisen. Down-regulated genes were selected because of a sizeable change in expression that indicated virtually complete loss of function in most cases. Upregulated genes were the ones most consistently and highly expressed. Furthermore, these genes exhibited the same expression changes in cancers as they did in the Barrett's epithelia.
Gene expression changes with progression to invasive cancer. To determine changes associated with progression to invasive adenocarcinoma, we individually compared gene expression in each of three cancers with that in the corresponding Barrett's epithelium from which each had arisen. Gene expression changes found in the Barrett's epithelia were generally present in the cancers that had arisen from them. Gene expression in cancers differed from that in the Barrett's epithelia from which they had arisen primarily by the up-regulation of genes, many of which were associated with tissue remodeling and invasiveness (Table 2) . Several matrix metalloproteinases and metalloproteinase inhibitors were increased. Transcripts for many types of collagen and proteoglycans were increased as well as for proteins that bind to these and other extracellular components. Gene expression increased for factors classified as hormones or cytokines with influence on growth control. These changes suggest a gain in function that correlates with increased invasiveness accompanying progression to cancer.
Gene expression in cancer without identifiable Barrett's epithelium. The gene expression changes found in cancers without identifiable Barrett's epithelium were the same as those found in cancers arising from a Barrett's epithelium, with only a relatively small number of exceptions. The number of genes overexpressed in cancers without a Barrett's epithelium, however, was almost twice that found in cancers that had arisen from a Barrett's mucosa ( Table 1) . As was the case for cancers arising from a Barrett's epithelium, many of these overexpressed genes were associated with tissue remodeling and invasiveness. Expression of a few such genes, however, seemed to be genuinely increased in one group of cancers and decreased in the other. For example, genes for collagen type III a1 (COL3A1) and matrix metalloproteinase 1 (MMP1) both exhibited decreased expression in cancers arising from a Barrett's epithelium and increased expression in cancers without evident Barrett's epithelium. Conversely, matrix metalloproteinase 7 (MMP7), a-1-antichymotrypsin (SERPINA3), and fibroblast growth factor receptor 2 (FGFR2) were up-regulated in cancers arising from a Barrett's epithelium and down-regulated in the cancers without evident Barrett's epithelium. Because these genes govern extracellular tissue components, differences in their expression between groups of cancers may perhaps reflect a slightly different interaction of the cancers with the underlying tissue.
Discussion
Previous studies have shown that gene expression profiling of surgical specimens, endoscopic biopsies, and cultured cell lines can distinguish among squamous cell carcinoma of the esophagus, esophageal adenocarcinoma, and Barrett's metaplastic epithelium without dysplasia or cancer (14 -16) . The reference probe in two such studies was composed of a RNA mixture derived from various nonesophageal cell lines (14, 15) , and in the third study, both normal esophageal squamous epithelial tissue and cell lines were used (16) In the latter study, gene expression profiles in cancer cell lines were found to be notably different from those of cancer tissue specimens. Novel aspects of our study are that (a) we used biopsies from the Barrett's epithelia of patients without cancer or dysplasia as a reference rather than nonesophageal cell lines or normal esophageal squamous epithelial tissue and (b) we did gene expression profiling on endoscopic biopsies of the Barrett's epithelia from which cancer had arisen as well as the cancers themselves. Measuring gene expression changes in the Barrett's epithelia from which cancer had arisen was particularly useful both in exploring the mechanism by which adenocarcinoma arises from Barrett's epithelium and in evaluating the potential use of gene expression as a marker predictive of malignant progression in Barrett's epithelium. 
Gene Expression in Esophageal Adenocarcinoma
Research. We did not find clear indication that differential expression of genes involved in cell cycle regulation contributes to cell proliferation in esophageal adenocarcinoma or the Barrett's epithelium from which it had arisen. One possible explanation for this observation may be that any changes in growth control had already occurred in the reference Barrett's epithelia from patients who had neither cancer nor dysplasia. Thus, no additional cell cycle dysregulation would be needed for progression from a benign Barrett's metaplasia to invasive adenocarcinoma. Indeed, differential expression of a large number of genes involved in G 2 -M functions and cell cycle check points has been reported in spontaneously arising 4N (G 2 -tetraploid) cell populations present in Barrett's epithelial cell cultures (17) . These tetraploid cell populations have been found in several human neoplasms and are associated with malignant progression. Another possibility is that reduced cell death rate, rather than an increased birth rate, could allow cells to accumulate. Down-regulation of genes induced during apoptosis in cancers suggests a reduced rate of apoptosis, although a definitive answer will require further evaluation of the cell life cycle in cancers. One further possibility is that individual cancers developed unique pathways toward unregulated growth. Unique changes in individual cancers would not be identified by this analysis, which sought consensus changes.
Although a change in expression of 1,097 genes was found in cancers and the Barrett's epithelia from which cancers had arisen, most of these genes are not among those expected to be expressed differentially as a frankly invasive tumor evolves. Many of the changes in gene expression that we observed reflect a change in differentiation and complexity of the tissue as the tumor phenotype emerges. As an example of how such changes in expression might come about, consider that the development of any tissue and maintenance of its integrity are dependent on communications between two or more cell types (18 -21) . In epithelia, these communications can occur through receptors or ligands present on each cell type, through paracrine stimulation, or across gap junctions. As a neoplasm develops, it becomes less reliant on these forms of cell-to-cell communication for survival. Removing one partner from a communicating group of cell types leads to phenotypic changes in remaining cell types. Thus, loss of intercellular communication could explain some of the changes in gene expression that we observed.
Columnar Barrett's epithelium exhibits enterocytic differentiation as evidenced by its expression of proteins associated with intestinal mucosal function, such as sucrase-isomaltase, cytokeratins, and mucins (22) (23) (24) (25) . We found that in Barrett's epithelia from which cancer had arisen the predominant change in gene expression was down-regulation of differentiation-specific genes involved in gastrointestinal mucosal functions, such as transport, metabolism, and mucous secretion. On average, the decrease in expression of differentiation-specific genes was substantial; however, individual variability in expression was equally striking and of uncertain origin. The degree to which expression of enterocytic differentiation is lost may represent simple variation among individuals, but it also may reflect the extent of neoplastic progression in a given individual specimen, as expression of differentiation-specific genes tended to be less in cancers than in the Barrett's epithelia from which cancers had arisen. The various possibilities cannot be addressed by this study because of the limited sample size. A further issue to be determined is the extent to which changes in expression of differentiation-specific genes may be secondary consequences rather than directly attributable to neoplastic transformation itself.
Barrett's epithelia from which cancer had arisen exhibited a decrease in expression of genes encoding proteins with putative roles in cellular defense against oxidative damage. Transcripts for proteins involved in the detoxification of xenobiotics were reduced in Barrett's epithelia from which cancer had arisen as well, indicating a decreased tolerance for various forms of chemical insult. Reduced protection against outside insults would place the epithelium at risk for further genetic damage and therefore may represent an early event in the progression to cancer. In addition to the possibility of impaired defenses against DNA damage, there is some evidence for a diminished capacity to repair DNA damage Inflammation is commonly present in esophageal adenocarcinoma as well as in Barrett's epithelium. Accordingly, changes in expression of genes associated with immune function and inflammatory response are to be expected in both cancer and the Barrett's epithelium from which it arises. Transcripts for proteins that promote or accompany inflammatory response were increased in both tissues. Decreased transcript for the IgGbinding protein FcgBP suggests increased susceptibility to infection, but whether this finding is of any significance in the neoplastic transformation of Barrett's epithelium is unknown. Surprisingly, expression of several genes located on the Y chromosome was evident in the reference metaplastic Barrett's epithelia but substantially decreased or virtually undetectable in both cancers and the Barrett's epithelia from which cancer had arisen. Very little is known about these genes; however, deletion of any one of the genes results in azoospermia (26) . This is not the first example of Y-linked gene expression in a tissue that has no role in sexual reproduction (27) or the first indication that progression of tumors of the esophagus might be influenced by changes on the Y chromosome, which is often entirely lost in cancer (28, 29) .
The observation that gene underexpression was the predominant change in Barrett's epithelia from which cancer had arisen suggests importance of a loss of function, rather than gain, in initiating the neoplastic progression from metaplasia to cancer. Many of the underexpressed genes govern differentiation, which is compatible with the model for development of cancer by regression to a dedifferentiated state. In contrast, gene expression changes with progression to invasive cancer reflect a distinct gain in function. That is, gene overexpression accounted for most changes in cancers individually compared with the Barrett's epithelium from which each had arisen. Many overexpressed genes were associated with tissue remodeling and invasiveness, which correlates with the more aggressive phenotype of invasive cancer.
Adenocarcinoma arises from an endoscopically identifiable Barrett's epithelium in 30% to 85% of patients (30, 31) . The remaining cancers may have overgrown the Barrett's epithelium from which they had arisen; however, it could be argued that adenocarcinoma may have arisen de novo without a precursor Barrett's epithelium. We first thought that if these two groups of cancers had different origins, then gene expression might differ as well. Indeed, gene expression in cancers without an identifiable Barrett's epithelium differed from those arising from a Barrett's mucosa by having nearly twice the number of overexpressed genes, many of which were involved in governing extracellular tissue components related to tissue remodeling. It is difficult to know, however, if this difference in gene expression between the two groups of cancers was the result of the tumors having distinctly different origins or whether it reflects only differences in growth properties of the two groups. Greater overexpression of genes associated with tissue remodeling and invasiveness in cancers without identifiable Barrett's epithelium could have led to a more aggressive cancer that overgrew the Barrett's mucosa.
It is remarkable that gene expression changes were already present in two of the three Barrett's epithelia from which cancer had arisen, although they were histologically indistinguishable from the reference Barrett's epithelia of patients who had neither cancer nor dysplasia. The high-grade dysplasia of the third Barrett's epithelium exhibited a greater number of gene expression changes that more closely resembled cancer than the two epithelia that were histologically identical to the reference Barrett's epithelia. Although the number of patients is small, these findings are compatible with the hypothesis that the histologic progression from Barrett's metaplasia to cancer through grades of dysplasia is associated with an underlying gradient of increasing changes in gene expression that begin before the development of dysplasia (Fig. 2) . This correlation of histologic progression with increasing changes in gene expression suggests that gene expression changes in biopsies taken from Barrett's epithelium could serve as a marker for neoplastic progression that could be used to predict which individuals are at greatest risk for developing cancer. To gain an understanding of the findings that might be expected in a larger study population, we developed a list of candidate gene predictors. Not surprisingly, this list is dominated by genes associated with epithelial differentiation, with a smaller number of genes linked to tissue remodeling and growth.
Although it is clear that progression to cancer is marked by a characteristic sequence of gene underexpression followed by overexpression, we do not yet know the exact mechanism by which this sequence of changes unfolds. More than one pathway of gene expression change could lead to cancer, but specific changes might be critical and common to most or all pathways. This exploratory study shows the potential for using these gene expression changes as a marker of malignant progression in Barrett's epithelium; however, we do not know the extent of variation in Barrett's epithelial gene expression between individuals or the effect of sampling within the Barrett's mucosa of a given individual. Further studies in a larger number of patients are needed to determine the specific gene expression changes that are most predictive of which individuals with Barrett's esophagus are at greatest risk for progression to cancer. Fig. 2 . Molecular model for the neoplastic progression from Barrett's metaplastic epithelium to esophageal adenocarcinoma through grades of dysplasia. This sequence of histologic changes is associated with a gradient of increasing changes in gene expression. An increasing gradient in number of underexpressed and overexpressed genes is indicated by the progressive darkening of the respective bars underlying the histologic stages. In this model, cancer develops by regression to a dedifferentiated state as evidenced by an early loss of gene function governing differentiation that begins before histologic change. Progression to cancer is associated with later overexpression of genes related to invasiveness and tissue remodeling.
